Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

American Funds New Perspective A

Vanguard Dividend Appreciation ETF

AB Large Cap Growth A

State St S&P 500® Indx SL Cl III

Blackrock Eq Idx Fund CF

Jensen Quality Growth J

Vanguard Health Care ETF

Blackrock Russ 1000 Eq Idx Composite

Russell 1000 Index Fund

Calvert Equity A

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

iShares Core S&P 500 ETF

Vanguard Growth Index Investor

AllianceBernstein US L/C Growth Eqty MF

The Health Care Select Sector SPDR® ETF

Vanguard Institutional Index I

Capital Group New Perspective Comp

Vanguard Group Inc

BlackRock Inc

Wells Fargo & Co

Northern Trust Corp

Bank of New York Mellon Corp

NORGES BANK

Mizuho Securities USA Inc

Nuveen Asset Management, LLC

Unisphere Establishment

FMR Inc

Brown Advisory Holdings Inc

Legal & General Group PLC

State Street Corp

State Farm Mutual Automobile Ins Co

AllianceBernstein L.P.

Bank of America Corp

Morgan Stanley - Brokerage Accounts

Geode Capital Management, LLC

Capital World Investors

Polen Capital

Zoetis Inc

Ms. Kristin C. Peck

CEO & Director

Ms. Wafaa  Mamilli

EVP & Group President for China, Brazil and Preci. Animal Health

Dr. Robert J. Polzer Ph.D.

Executive VP and President of Research & Development

Mr. Keith  Sarbaugh

Executive VP & Chief Digital and Technology Officer

Mr. Steven  Frank

Vice President of Investor Relations

Ms. Roxanne  Lagano

Executive VP, General Counsel & Corporate Secretary

Mr. William  Price

VP & Chief Communications Officer

Ms. Julie A. Fuller

Executive VP, Chief Human Resources Officer & Global Operations

Ms. Jeannette Ferran Astorga

Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer

Mr. Nick  Ashton

Executive VP and President of Global Manufacturing & Supply

ZTS's next earnings is on February 11, 2025 (Before Market Open)

ZTS's latest dividend is 0.432 USD on July 18, 2024

Zoetis Inc (ZTS) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Zoetis Inc (ZTS) Earnings Report Date and History | NYSE

ZTS's next earnings is on February 11, 2025 (Before Market Open)

When is the earnings report for ZTS?

ZTS Earnings History

ZTS's latest dividend is 0.432 USD on July 18, 2024

ZTS Stock Discussion Forum and Message Board

News for NYSE: ZTS